RT Journal Article
SR Electronic
A1 Nichols, Emma Hitt
T1 LTAD Improved Outcomes in Prostate Cancer
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 31
SP 13
OP 14
DO 10.1177/155989771431012
UL http://mdc.sagepub.com/content/14/31/13.2.abstract
AB Previous study findings support that overall survival is improved with hormone therapy and conventional-dose radiotherapy in patients with intermediate and high-risk prostate cancer and that biochemical outcomes as well as clinical outcomes were improved with dose-escalated radiotherapy. This article discusses the findings of a phase 3 trial that compared long-term androgen deprivation therapy with short-term androgen deprivation therapy in patients with intermediate and high-risk localized prostate cancer treated with high-dose radiotherapy.